"This was discussed on the boards years ago.  Yes it sucks, but it's FDA policy and there are good reasons for keeping those folks in the data analysis."

I am sure there is a reason for it,,,,,,,,,it must be assumed to do so makes perfect sense to statisticians,,,,,,it just seems counter intuitive that non participation in a trial where the tinyest of differences could make for a win or lose end result that such inclusion could possible taint vital data. Thats just what my common sense tells me, and I assume that such issues have arisen in other trials which signaled for inclusion, but hey I have a simple grade 10 general math equivalent. Just saying. But I am still holding tight,,and assuming once again, one of many of the proverbial three blind mice invested in this cutting edge science.